Want to see ISRG full AI Analyst Report?
ISRG Stock Chart & Stats
$371.84
$13.91(4.12%)
At close: 4:00 PM EDT
$371.84
$13.91(4.12%)
Day’s Range― - ―
52-Week Range$328.57 - $603.88
Previous CloseN/A
Volume15.48K
Average Volume (3M)2.19M
Market Cap
$154.74B
Enterprise Value$136.97B
Total Cash (Recent Filing)$5.22B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)52.3
Beta1.20
Next Earnings
Jan 26, 2027EPS Estimate
2.94Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.85
Shares Outstanding353,278,050
10 Day Avg. Volume1,944,494
30 Day Avg. Volume2,189,658
Financial Highlights & Ratios
PEG Ratio3.17
Price to Book (P/B)11.34
Price to Sales (P/S)20.08
P/FCF Ratio81.16
Enterprise Value/Market Cap0.89
Enterprise Value/Revenue12.41
Enterprise Value/Gross Profit18.62
Enterprise Value/Ebitda30.19
Forecast
1Y Price Target
$498.26Price Target Upside34.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering20
EPS Forecast (FY)10.81
Revenue Forecast (FY)$11.76B
Bulls Say, Bears Say
Bulls Say
Recurring Revenue ModelThe large recurring share of revenue ties ongoing sales to procedures performed on the installed base, while instruments, accessories, and service create repeat purchases. This model supports revenue visibility and lets system placements build future procedure and service potential.
Installed Base And International ExpansionA growing global installed base expands the platform available for future procedures and recurring consumables revenue. International procedure growth and adoption across more than 70 countries broaden the company’s market opportunity and reduce reliance on a single geography.
Profitability And Balance Sheet StrengthHigh gross and operating margins indicate meaningful economic strength, while minimal leverage preserves financial flexibility. The combination of improving profitability, growing equity, and strong cash generation gives Intuitive capacity to fund innovation and withstand operating volatility.
Bears Say
Slowing U.S. Procedure GrowthSlower U.S. procedure growth could moderate the pace of recurring instrument, accessory, and service revenue in the company’s largest established market. Continued exposure to healthcare enrollment and reimbursement changes may also make domestic growth less predictable.
Revenue-per-Procedure PressureLower revenue per procedure directly pressures the economics of the recurring razor-and-blades model, even if procedure volumes continue rising. The country-by-country rollout extends the period of mix and pricing transition and may weigh on revenue growth through 2027.
Rising Operating And Input CostsHigher operating and development costs can reduce the conversion of revenue growth into operating income while several technology programs advance. Freight and semiconductor costs add further pressure, requiring productivity and cost reductions to preserve the company’s strong margin profile.
Intuitive Surgical News
ISRG FAQ
What was Intuitive Surgical’s price range in the past 12 months?
Intuitive Surgical lowest stock price was $328.57 and its highest was $603.88 in the past 12 months.
What is Intuitive Surgical’s market cap?
Intuitive Surgical’s market cap is $154.74B.
When is Intuitive Surgical’s upcoming earnings report date?
Intuitive Surgical’s upcoming earnings report date is Jan 26, 2027 which is in 96 days.
How were Intuitive Surgical’s earnings last quarter?
Intuitive Surgical released its earnings results on Oct 20, 2026. The company reported $3 earnings per share for the quarter, beating the consensus estimate of $2.646 by $0.354.
Is Intuitive Surgical overvalued?
According to Wall Street analysts Intuitive Surgical’s price is currently Undervalued.
Does Intuitive Surgical pay dividends?
Intuitive Surgical does not currently pay dividends.
What is Intuitive Surgical’s EPS estimate?
Intuitive Surgical’s EPS estimate is 2.94.
How many shares outstanding does Intuitive Surgical have?
Intuitive Surgical has 353,278,050 shares outstanding.
What happened to Intuitive Surgical’s price movement after its last earnings report?
Intuitive Surgical reported an EPS of $3 in its last earnings report, beating expectations of $2.646. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Intuitive Surgical?
Currently, no hedge funds are holding shares in ISRG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Intuitive Surgical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$498.26 (34.00% Upside)
$498.26 (34.00% Upside)
Blogger Sentiment
Bullish
ISRG Sentiment 83%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Increased
By 469.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 0.8%
Last 30 Days ▲ 0.6%
Last 30 Days ▲ 0.6%
News Sentiment
Very Bullish
Bullish news 80%
Bearish news 20%
Bearish news 20%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.46%
12-Months-Change
Fundamentals
Return on Equity
17.00%
Trailing 12-Months
Asset Growth
-0.01%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Intuitive Surgical
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
ISRG Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was strongly positive overall. Intuitive reported broad-based procedure, revenue, system placement and installed-base growth, improving non-GAAP profitability, strong adoption of da Vinci 5 and SP, international expansion, favorable clinical evidence and a substantial product and technology pipeline. The main negatives were slower U.S. da Vinci procedure growth, challenging conditions in China, planned 3% to 5% revenue-per-procedure pressure from pricing actions, higher operating expenses and development costs, a $450 million litigation settlement charge and lower GAAP net income.View all ISRG earnings summariesISRG Revenue Breakdown
67.72% U.S.
32.28% Outside of U.S
ISRG Stock 12 Month Forecast
Average Price Target
$498.26
▲(34.00% Upside)
Technical Analysis
Ownership Overview
0.47% Insiders
21.99% Mutual Funds
1.62% Other Institutional Investors
48.39% Public Companies and Individual Investors